Sandoz Strikes $195m Deal On US Price-Fixing
Admits Role In Antitrust Conspiracies As Part Of US Investigation
Executive Summary
Sandoz has agreed to pay a $195m criminal penalty, the largest for a US antitrust case, as part of a deferred prosecution agreement with the US Department of Justice to resolve antitrust allegations as part of the country’s ongoing investigation into generic price-fixing.
You may also be interested in...
Induced Infringement And Price Fixing Among Legal Headlines In 2021
In 2021, courts across the US and beyond continued to weigh key patent litigation fights, alongside the thorny issue of induced infringement via label carve outs and controversial charges for generic price fixing.
Sandoz, Apotex And Taro Strike Civil Settlements On Price-Fixing
Three civil settlements worth more than $447m in total have been reached with the US Department of Justice by Sandoz, Apotex and Sun’s Taro to resolve allegations over price-fixing. The deals follow criminal penalties previously paid by the three companies.
Teva State Settlement On Price-Fixing Could Be First Of Many
Teva has struck a $950,000 deal to settle US price-fixing litigation with the state of Mississippi, in what the firm anticipates could be the first of multiple settlements with individual US states.